Home » Healthcare » Subdermal Contraceptive Implants Market

Subdermal Contraceptive Implants Market By Type (Etonogestrel Implant, Levonorgestrel Implant, and Others) By Application (Hospital, Clinic, & Research facilities)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Price: $4999

Published: | Report ID: 15365 | Report Format : PDF

Key Highlights of the report

How are the major segments performing in the Subdermal Contraceptive Implants market?

  • In 2022, the etonogestrel implants segment accounted for the largest market share owing to higher clinical effectiveness and an expanding adoption rate.
  • In 2022, the hospitals’ segment was anticipated to hold a prominent share in the global subdermal contraceptive implants market owing to the rising number of subdermal contraceptive implant procedures performed in hospitals.

What is the Market Size of Subdermal Contraceptive Implants regarding value?

The global subdermal contraceptive implants market is anticipated to grow at a substantial CAGR of 3.30% in the upcoming years. The global subdermal contraceptive implants industry was estimated to be worth USD 846.9 million in 2022 and was expected to be worth USD 1029.04 million by 2028.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Which region dominated the Subdermal Contraceptive Implants Market?

In 2022, North America occupied the largest subdermal contraceptive implants market share and was expected to continue with the current trend of dominance during the forecast period. Factors such as rising disposable income, increased awareness regarding contraceptives, and technological advancements are expected to fuel the market’s growth in the region. Additionally, supportive government schemes in the field and rising demand for contraceptive owing to increasing abortions in the region is expected to contribute to sustainable market growth.

How the US Market is Performing in the Subdermal Contraceptive Implants Market?

In 2022, the United States was expected to be the largest contributor to the North American subdermal contraceptive implants market during the forecast period. Factors such as the presence of a well-developed infrastructure, increasing prevalence of sexually transmitted diseases, and rising healthcare expenditure will fuel the market growth in the country. Also, the presence of many dominant players in the country will widen the market’s footprint during the forecast period.

How is the economy impacting the global Subdermal Contraceptive Implants Market growth?

The economic impact on global subdermal contraceptive implants is expected to be substantially low. The rising popularity of minimally invasive surgeries and the lowering of costs pushed the market’s growth during the forecast period. According to the WHO, nearly 64.0% of married women use a contraceptive solution, whereas 57% rely on modern contraceptive methods.

What is the competitive environment of the Subdermal Contraceptive Implants Market?

The subdermal contraceptive implants industry competitive environment provides information on the entire economic profit made by suppliers and businesses, the sales and revenues created in this sector, the market share globally, the business organization summary, the introduction of new products, and the opportunities for the industrial subdermal contraceptive implants market. For instance, in November 2016, Livoplant/Sino-implant announced that they received approval from the United Nations for purchasing their country programs through the WHO review panel. In January 2016, Bayer announced that they were reducing the price of JADELLE by more than 50%. his move is fast-tracked to make medicine affordable and accessible to women in developing countries.

Executive Summary

What are the key trends in the Subdermal Contraceptive Implants Market?

  • Technological advancements and rising research and development investments will support the global market during the forecast period.
  • During the forecast period, the dominant leaders in the global subdermal contraceptive implants are expected to increase their product portfolio by merging with other like-minded players across the globe. For instance, in February 2018, DKT International announced they were collaborating with Shanghai Dahua Pharmaceuticals, Co. Ltd to market Levoplant, a contraceptive implant.

What are the Latest Product Offerings by Key Players in the Subdermal Contraceptive Implants Market?

Some prominent players in the subdermal contraceptive implants market are Bayer AG, Merck & Co. Inc., and Shanghai Dahua Pharmaceutical Co., Ltd. Subdermal contraceptive implants are inserted beneath the skin of the upper arm. The implant releases a pregestational hormone that prevents sperm from reaching the egg. Some implants also can suppress ovulation, reducing the risk of unwanted pregnancies. Bayer AG has a product called Jadelle, registered in 41 countries. However, the product is awaiting registration in 8 of those countries. It can be bought in a single-pack presentation for sale through the private sector. Merck & Co. Inc has a product known as Implanon and Implanon NXT. Implanon is registered in 60 countries. However, the review of these products is underway in 11 countries. Implanon NXT is registered in 38 countries, wherein registration in 11 additional countries is pending. Shanghai Dahua Pharmaceutical Co., Ltd has a product known as the Sino-implant. It is registered in 24 countries and is pending registration in 11 additional countries. Which are the key investments by the Subdermal Contraceptive Implants Market players?

The dominant players operating in the subdermal contraceptive implants market are merging and creating partnerships with other players to widen their global footprint. The market is highly consolidated due to very few major players. Rising spending on research and development activities is expected to widen their product portfolios during the forecast period. For instance, In March 2022, the Bill and Melinda Gates Foundation announced that they would offer more than USD 280 million per year from 2021 to 2030 for developing novel and improved contraceptive technologies and launching supportive family planning programs. These programs are expected to reflect the ongoing preferences of local communities.

Some major players in the subdermal contraceptive implants market are Merck & Co., Inc., Shanghai Dahua Pharmaceutical Co., Ltd, Bayer AG, Wyeth Pharmaceuticals, Baxter, BD, Gerresheimer AG, Pfizer, Inc., Novartis AG, Schott AG, Eli Lilly and Company, Sandoz International GmbH, Terumo Corporation, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services, Inc., SHL Medical AG, Insulet Corporation and E3D Elcam Drug Delivery Devices among others.

What are the Major Driving Factors for the Subdermal Contraceptive Implants Market?

The primary drivers for the significant growth in the global subdermal contraceptive implants market are the rising utilization of modern contraceptive methods and increasing awareness regarding sexual health and family planning. Factors such as the rising number of supportive government policies and potential abortions are expected to add to healthcare costs. This will positively impact the global subdermal contraceptive implants market during the forecast period. Additional valuable properties of subdermal contraceptive implants include higher effectivity, cost-efficiency, and usefulness for women allergic to estrogen. The rising number of unwanted pregnancies and an increasing number of initiatives for educating and preventing the spread of unwanted abortions and pregnancies will fuel the growth of the global subdermal contraceptive implants market during the forecast period.

What are the Major Risks for the Subdermal Contraceptive Implants Market?

The global subdermal contraceptive implants market is also plagued with a wide range of social and economic restraints. Factors such as the devastating result of unintended pregnancy and rising maternal and neonatal morbidity and mortality are expected to cause hindrances to global market growth. Factors such as the social isolation caused by increased unintended pregnancy through exposure to unprotected intercourse and reproductive coercion will further contribute to the social stigma.

Which is the key application in the Subdermal Contraceptive Implants Market?

In 2022, the hospitals’ segment was expected to account for the largest segmental share in terms of revenue. Hospitals have advanced diagnostics systems and a wide range of treatment options that will likely boost the segmental prospect. Additionally, various governments across the globe are partnering with hospitals to provide male and female contraceptives at a lower price. In the Asia Pacific region, in countries such as China and India, government bodies provide numerous free contraceptives. These measures are taken to control the growing population and increasing prevalence of sexually transmitted diseases in the region. These factors will fuel the segmental growth during the forecast period.

Subdermal Contraceptive Implants Market

How is the Subdermal Contraceptive Implants Market performing in regions?

The region of Asia Pacific is expected to grow with the fastest-growing CAGR during the forecast period. Factors such as rising awareness regarding sex education and favorable government initiatives will fuel the market’s growth in the region. Additionally, the rising availability of subdermal implants at lowered costs and enhanced access to contraceptive methods for women in need will further increase the footprint of the subdermal contraceptive implants market in the region. Factors such as higher efficacy, longer periods of contraceptive protection, and easy injection and implant removal will further drive increased market growth.

What is the regulatory landscape for the Subdermal Contraceptive Implants Market?

FDA’s regulations for medical devices such as intrauterine devices, diaphragms, and condoms are all formed on the same guidelines. They are regulated by the FDA’s Center for Devices and Radiological Health. Although the regulatory forms and terminology applicable to devices differ from those of drugs, the safety issues also vary for various drugs and devices.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

What are the major players planning for the future of the Subdermal Contraceptive Implants Market?

The prominent players in the global subdermal contraceptive implants industry have a good market presence. The competitive presence is highly consolidated as players have a strong hold on their respective consumers. For instance, in January 2022, Organon announced the public listings for NEXPLANON (etonogestrel extended-release subdermal implant) in Ontario, British Columbia, and Nova Scotia. Similarly, in November 2021, Organon announced the public listing for NEXPLANON in Quebec under the Régie de l’assurance Maladie du Québec.

REPORT ATTRIBUTE DETAILS
Subdermal Contraceptive Implants Market by Volume No
Subdermal Contraceptive Implants Market by Value Yes
Subdermal Contraceptive Implants Market, Tornado Analysis Yes
Subdermal Contraceptive Implants Market, STAR Analysis Yes
Subdermal Contraceptive Implants Market, SRC Analysis Yes
Subdermal Contraceptive Implants Market Pricing Analysis Yes (On Demand)
 

Subdermal Contraceptive Implants Market Segment Analysis

By Type (Etonogestrel Implant, Levonorgestrel Implant, and Others)

By Application (Hospital, Clinic, & Research facilities)

 

 

 

Subdermal Contraceptive Implants Market, Regional Analysis

North America (US and Canada)

Europe (Germany, UK, France, Italy, Spain, and Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, South East Asia, and Rest of Asia Pacific)

Latin America (Brazil, Mexico, and Rest of Latin America)

Middle East and Africa (GCC Countries, South Africa, and Rest of Middle East and Africa)

 

Subdermal Contraceptive Implants Market Key Companies

Merck & Co., Inc., Shanghai Dahua Pharmaceutical Co., Ltd, Bayer AG, Wyeth Pharmaceuticals, Baxter, BD, Gerresheimer AG, Pfizer, Inc., Novartis AG, Schott AG, Eli Lilly and Company, Sandoz International GmbH, Terumo Corporation, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services, Inc., SHL Medical AG, Insulet Corporation and E3D Elcam Drug Delivery
 

Subdermal Contraceptive Implants Market Competitive Landscape

Market Share Analysis

Competitive Benchmarking

Key Players Market Positioning

Geographical Presence Analysis

Major Strategies Adopted

Segmentation of Global Subdermal Contraceptive Implants Market-

Global Subdermal Contraceptive Implants Market – By Type

  • Etonogestrel implant
  • Levonorgestrel implant
  • Others

Global Subdermal Contraceptive Implants Market – By Application

  • Hospital
  • Clinic
  • Research facilities

Global Subdermal Contraceptive Implants Market – By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Subdermal Contraceptive Implants Market
2.2. Global Subdermal Contraceptive Implants Market, By Type
2.3. Global Subdermal Contraceptive Implants Market, By Application
2.4. Global Subdermal Contraceptive Implants Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Subdermal Contraceptive Implants Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Type
3.5.2. Application
3.5.3. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Subdermal Contraceptive Implants Market
7.1. Global Subdermal Contraceptive Implants Market, by Type, 2017-2030(US$ Bn)
7.1.1. Overview
7.1.2. Global Subdermal Contraceptive Implants Market, By Type, 2022 vs 2030 (in%)
7.1.3. Global Subdermal Contraceptive Implants Market, By Etonogestrel Implant, 2017-2030 (US$ Bn)
7.1.4. Global Subdermal Contraceptive Implants Market, By Levonorgestrel Implant, 2017-2030 (US$ Bn)
7.1.5. Global Subdermal Contraceptive Implants Market, By Others, 2017-2030 (US$ Bn)
7.2. Global Subdermal Contraceptive Implants Market, by Application, 2017-2030(US$ Bn)
7.2.1. Overview
7.2.2. Global Subdermal Contraceptive Implants Market, By Application, 2022 vs 2030 (in%)
7.2.3. Global Subdermal Contraceptive Implants Market, By Hospital, 2017-2030 (US$ Bn)
7.2.4. Global Subdermal Contraceptive Implants Market, By Clinic, 2017-2030 (US$ Bn)
7.2.5. Global Subdermal Contraceptive Implants Market, By Research facilities, 2017-2030 (US$ Bn)

8. North America Subdermal Contraceptive Implants Market Analysis
8.1. North America Subdermal Contraceptive Implants Market, by Type, 2017-2030(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Subdermal Contraceptive Implants Market, by Application, 2017-2030(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Subdermal Contraceptive Implants Market, by Country, 2017-2030 (US$ Bn)
8.3.1. U.S.
8.3.1.1. U.S. Subdermal Contraceptive Implants Market Estimates and Forecast, 2017-2030 (US$ Bn)
8.3.1.2. U.S. Subdermal Contraceptive Implants, By Type, 2017-2030 (US$ Bn)
8.3.1.3. U.S. Subdermal Contraceptive Implants, By Application, 2017-2030 (US$ Bn)
8.3.2. Canada
8.3.2.1. Canada Subdermal Contraceptive Implants Market Estimates and Forecast, 2017-2030 (US$ Bn)
8.3.2.2. Canada Subdermal Contraceptive Implants, By Type, 2017-2030 (US$ Bn)
8.3.2.3. Canada Subdermal Contraceptive Implants, By Application, 2017-2030 (US$ Bn)

9. Europe Subdermal Contraceptive Implants Market Analysis
9.1. Europe Subdermal Contraceptive Implants Market, by Type, 2017-2030(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Subdermal Contraceptive Implants Market, by Application, 2017-2030(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Subdermal Contraceptive Implants Market, by Country, 2017-2030 (US$ Bn)
9.3.1. Germany
9.3.1.1. Germany Subdermal Contraceptive Implants Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.3.1.2. Germany Subdermal Contraceptive Implants, By Type, 2017-2030 (US$ Bn)
9.3.1.3. Germany Subdermal Contraceptive Implants, By Application, 2017-2030 (US$ Bn)
9.3.2. France
9.3.2.1. France Subdermal Contraceptive Implants Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.3.2.2. France Subdermal Contraceptive Implants, By Type, 2017-2030 (US$ Bn)
9.3.2.3. France Subdermal Contraceptive Implants, By Application, 2017-2030 (US$ Bn)
9.3.3. UK
9.3.3.1. UK Subdermal Contraceptive Implants Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.3.3.2. UK Subdermal Contraceptive Implants, By Type, 2017-2030 (US$ Bn)
9.3.3.3. UK Subdermal Contraceptive Implants, By Application, 2017-2030 (US$ Bn)
9.3.4. Italy
9.3.4.1. Italy Subdermal Contraceptive Implants Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.3.4.2. Italy Subdermal Contraceptive Implants, By Type, 2017-2030 (US$ Bn)
9.3.4.3. Italy Subdermal Contraceptive Implants, By Application, 2017-2030 (US$ Bn)
9.3.5. Spain
9.3.5.1. Spain Subdermal Contraceptive Implants Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.3.5.2. Spain Subdermal Contraceptive Implants, By Type, 2017-2030 (US$ Bn)
9.3.5.3. Spain Subdermal Contraceptive Implants, By Application, 2017-2030 (US$ Bn)
9.3.6. Rest of Europe
9.3.6.1. Rest of Europe Subdermal Contraceptive Implants Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.3.6.2. Rest of Europe Subdermal Contraceptive Implants, By Type, 2017-2030 (US$ Bn)
9.3.6.3. Rest of Europe Subdermal Contraceptive Implants, By Application, 2017-2030 (US$ Bn)

10. Asia Pacific Subdermal Contraceptive Implants Market Analysis
10.1. Asia Pacific Subdermal Contraceptive Implants Market, by Type, 2017-2030(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Subdermal Contraceptive Implants Market, by Application, 2017-2030(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Subdermal Contraceptive Implants Market, by Country, 2017-2030 (US$ Bn)
10.3.1. China
10.3.1.1. China Subdermal Contraceptive Implants Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.1.2. China Subdermal Contraceptive Implants, By Type, 2017-2030 (US$ Bn)
10.3.1.3. China Subdermal Contraceptive Implants, By Application, 2017-2030 (US$ Bn)
10.3.2. Japan
10.3.2.1. Japan Subdermal Contraceptive Implants Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.2.2. Japan Subdermal Contraceptive Implants, By Type, 2017-2030 (US$ Bn)
10.3.2.3. Japan Subdermal Contraceptive Implants, By Application, 2017-2030 (US$ Bn)
10.3.3. India
10.3.3.1. India Subdermal Contraceptive Implants Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.3.2. India Subdermal Contraceptive Implants, By Type, 2017-2030 (US$ Bn)
10.3.3.3. India Subdermal Contraceptive Implants, By Application, 2017-2030 (US$ Bn)
10.3.4. South Korea
10.3.4.1. South Korea Subdermal Contraceptive Implants Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.4.2. South Korea Subdermal Contraceptive Implants, By Type, 2017-2030 (US$ Bn)
10.3.4.3. South Korea Subdermal Contraceptive Implants, By Application, 2017-2030 (US$ Bn)
10.3.5. South-East Asia
10.3.5.1. South-East Asia Subdermal Contraceptive Implants Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.5.2. South-East Asia Subdermal Contraceptive Implants, By Type, 2017-2030 (US$ Bn)
10.3.5.3. South-East Asia Subdermal Contraceptive Implants, By Application, 2017-2030 (US$ Bn)
10.3.6. Rest of Asia Pacific
10.3.6.1. Rest of Asia Pacific Subdermal Contraceptive Implants Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.6.2. Rest of Asia Pacific Subdermal Contraceptive Implants, By Type, 2017-2030 (US$ Bn)
10.3.6.3. Rest of Asia Pacific Subdermal Contraceptive Implants, By Application, 2017-2030 (US$ Bn)

 

11. Latin America Subdermal Contraceptive Implants Market Analysis
11.1. Latin America Subdermal Contraceptive Implants Market, by Type, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Subdermal Contraceptive Implants Market, by Application, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Subdermal Contraceptive Implants Market, by Country, 2017-2030 (US$ Bn)
11.3.1. Brazil
11.3.1.1. Brazil Subdermal Contraceptive Implants Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.1.2. Brazil Subdermal Contraceptive Implants, By Type, 2017-2030 (US$ Bn)
11.3.1.3. Brazil Subdermal Contraceptive Implants, By Application, 2017-2030 (US$ Bn)
11.3.2. Mexico
11.3.2.1. Mexico Subdermal Contraceptive Implants Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.2.2. Mexico Subdermal Contraceptive Implants, By Type, 2017-2030 (US$ Bn)
11.3.2.3. Mexico Subdermal Contraceptive Implants, By Application, 2017-2030 (US$ Bn)
11.3.3. Rest of Latin America
11.3.3.1. Rest of Latin America Subdermal Contraceptive Implants Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.3.2. Rest of Latin America Subdermal Contraceptive Implants, By Type, 2017-2030 (US$ Bn)
11.3.3.3. Rest of Latin America Subdermal Contraceptive Implants, By Application, 2017-2030 (US$ Bn)

12. Middle East and Africa Subdermal Contraceptive Implants Market Analysis
12.1. Middle East and Africa Subdermal Contraceptive Implants Market, by Type, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Subdermal Contraceptive Implants Market, by Application, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Subdermal Contraceptive Implants Market, by Country, 2017-2030 (US$ Bn)
12.3.1. GCC Countries
12.3.1.1. GCC Countries il Subdermal Contraceptive Implants Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.1.2. GCC Countries Subdermal Contraceptive Implants, By Type, 2017-2030 (US$ Bn)
12.3.1.3. GCC Countries Subdermal Contraceptive Implants, By Application, 2017-2030 (US$ Bn)
12.3.2. South Africa
12.3.2.1. South Africa Subdermal Contraceptive Implants Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.2.2. South Africa Subdermal Contraceptive Implants, By Type, 2017-2030 (US$ Bn)
12.3.2.3. South Africa Subdermal Contraceptive Implants, By Application, 2017-2030 (US$ Bn)
12.3.3. Rest of Middle East and Africa
12.3.3.1. Rest of Middle East and Africa Subdermal Contraceptive Implants Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.3.2. Rest of Middle East and Africa Subdermal Contraceptive Implants, By Type, 2017-2030 (US$ Bn)
12.3.3.3. Rest of Middle East and Africa Subdermal Contraceptive Implants, By Application, 2017-2030 (US$ Bn)

13. Company Profiles
13.1. Merck & Co., Inc (U.S.)
13.1.1. Company Overview
13.1.2. Products/Services Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2022)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. Shanghai Dahua Pharmaceutical Co., Ltd (China)
13.3. Bayer AG (Germany)
13.4. Wyeth Pharmaceuticals (U.S.)
13.5. Baxter (U.S.)
13.6. BD (U.S.)
13.7. Gerresheimer AG (Germany)
13.8. Pfizer, Inc. (U.S.)
13.9. Novartis AG (Switzerland)
13.10. Schott AG (Germany)
13.11. Eli Lilly and Company (U.S.)
13.12. Sandoz International GmbH (Germany)
13.13. Terumo Corporation (Japan)
13.14. Teva Pharmaceutical Industries Ltd (Israel)
13.15. West Pharmaceutical Services, Inc (U.S.)
13.16. SHL Medical AG (Switzerland)
13.17. Insulet Corporation (U.S.)
13.18. Merom Hagalil, Baram (Israel)

List of Figures
FIG. 1 Global Subdermal Contraceptive Implants Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Subdermal Contraceptive Implants Market Segmentation
FIG. 4 Global Subdermal Contraceptive Implants Market, by Type, 2022 (US$ Bn)
FIG. 5 Global Subdermal Contraceptive Implants Market, by Application, 2022 (US$ Bn)
FIG. 6 Global Subdermal Contraceptive Implants Market, by Geography, 2022 (US$ Bn)
FIG. 7 Attractive Investment Proposition, by Type, 2022
FIG. 8 Attractive Investment Proposition, by Application, 2022
FIG. 9 Attractive Investment Proposition, by Geography, 2022
FIG. 10 Global Market Share Analysis of Key Subdermal Contraceptive Implants Market Manufacturers, 2022
FIG. 11 Global Market Positioning of Key Subdermal Contraceptive Implants Market Manufacturers, 2022
FIG. 12 Global Subdermal Contraceptive Implants Market Value Contribution, By Type, 2022 & 2030 (Value %)
FIG. 13 Global Subdermal Contraceptive Implants Market, by Etonogestrel Implant, Value, 2017-2030 (US$ Bn)
FIG. 14 Global Subdermal Contraceptive Implants Market, by Levonorgestrel Implant, Value, 2017-2030 (US$ Bn)
FIG. 15 Global Subdermal Contraceptive Implants Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 16 Global Subdermal Contraceptive Implants Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 17 Global Subdermal Contraceptive Implants Market, by Hospital, Value, 2017-2030 (US$ Bn)
FIG. 18 Global Subdermal Contraceptive Implants Market, by Clinic, Value, 2017-2030 (US$ Bn)
FIG. 19 Global Subdermal Contraceptive Implants Market, by Research facilities, Value, 2017-2030 (US$ Bn)
FIG. 20 U.S. Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)
FIG. 21 Canada Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)
FIG. 22 Germany Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)
FIG. 23 France Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)
FIG. 24 U.K. Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)
FIG. 25 Italy Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)
FIG. 26 Spain Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)
FIG. 27 Rest of Europe Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)
FIG. 28 China Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)
FIG. 29 Japan Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)
FIG. 30 India Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)
FIG. 31 South Korea Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)
FIG. 32 Southeast Asia Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)
FIG. 33 Rest of Asia Pacific Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)
FIG. 34 Latin America Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)
FIG. 35 Brazil Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)
FIG. 36 Mexico Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)
FIG. 37 Rest of Latin America Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)
FIG. 38 Middle East & Africa Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)
FIG. 39 GCC Countries Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)
FIG. 40 South Africa Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)
FIG. 41 Rest of Middle East and Africa Subdermal Contraceptive Implants Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Subdermal Contraceptive Implants Market
TABLE 2 Global Subdermal Contraceptive Implants Market, by Competitive Benchmarking, 2022
TABLE 3 Global Subdermal Contraceptive Implants Market, by Geographical Presence Analysis, 2022
TABLE 4 Global Subdermal Contraceptive Implants Market, by Key Strategies Analysis, 2022
TABLE 5 Global Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 6 Global Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 7 Global Subdermal Contraceptive Implants Market, by Geography, 2017-2030 (US$ Bn)
TABLE 8 North America Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 9 North America Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 10 North America Subdermal Contraceptive Implants Market, by Country, 2017-2030 (US$ Bn)
TABLE 11 US Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 12 US Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 13 Canada Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 14 Canada Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 15 Europe Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 16 Europe Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 17 Europe Subdermal Contraceptive Implants Market, by Country, 2017-2030 (US$ Bn)
TABLE 18 Germany Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 19 Germany Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 20 France Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 21 France Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 22 UK Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 23 UK Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 24 Italy Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 25 Italy Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 26 Spain Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 27 Spain Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 28 Rest of Europe Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 29 Rest of Europe Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 30 Asia Pacific Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 31 Asia Pacific Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 32 Asia Pacific Subdermal Contraceptive Implants Market, by Country, 2017-2030 (US$ Bn)
TABLE 33 China Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 34 China Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 35 Japan Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 36 Japan Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 37 India Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 38 India Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 39 South Korea Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 40 South Korea Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 41 South East Asia Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 42 South East Asia Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 43 Rest of Asia Pacific Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 44 Rest of Asia Pacific Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 45 Latin America Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 46 Latin America Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 47 Latin America Subdermal Contraceptive Implants Market, by Country, 2017-2030 (US$ Bn)
TABLE 48 Brazil Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 49 Brazil Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 50 Mexico Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 51 Mexico Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 52 Rest of Latin America Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 53 Rest of Latin America Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 54 Middle East and Africa Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 55 Middle East and Africa Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 56 Middle East and Africa Subdermal Contraceptive Implants Market, by Country, 2017-2030 (US$ Bn)
TABLE 57 GCC Countries Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 58 GCC Countries Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 59 South Africa Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 60 South Africa Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)
TABLE 61 Rest of Middle East and Africa Subdermal Contraceptive Implants Market, by Type, 2017-2030 (US$ Bn)
TABLE 62 Rest of Middle East and Africa Subdermal Contraceptive Implants Market, by Application, 2017-2030 (US$ Bn)

Frequently Asked Questions:

How does COVID-19 Impact the global Subdermal Contraceptive Implants’ market?

COVID-19 has negatively impacted the market due to the outbreak of the COVID-19 pandemic, as all non-essential surgeries and healthcare procedures were postponed.

Which is the leading region of the market for Subdermal Contraceptive Implants?

North America accounted for the most heightened share in the global subdermal contraceptive implants market.

What are the key drivers for the growth of the Subdermal Contraceptive Implants market?

The rising need for modern contraceptive methods, awareness about sexual health and family planning, and increasing government initiatives drive the subdermal contraceptive implants market.

Which is the major segment in the Subdermal Contraceptive Implants market by type?

The etonogestrel Implants segment had a major share in the global market in 2022.

Which is the major segment in the Subdermal Contraceptive Implants market by application?

The hospitals’ segment had a major share in the global market.

Dental Implants and Prosthetics Market

Published:
Report ID: 42604

Surgical Tourniquets Market

Published:
Report ID: 42535

Vascular Access Systems Market

Published:
Report ID: 42543

Trigeminal Neuralgia Treatment Market

Published:
Report ID: 11788

Dermal Fillers and Botulinum Toxin Market

Published:
Report ID: 42459

Transcatheter Mitral Valve Market

Published:
Report ID: 42392

Computed Tomography Market

Published:
Report ID: 42344

Implantable Defibrillator Market

Published:
Report ID: 42239

Smart Contact Lens Market

Published:
Report ID: 10094

Pompe Disease Therapeutics Market

Published:
Report ID: 5989

Pre-Menstrual Syndrome Treatment Market

Published:
Report ID: 11248

Sterilization Equipment Market

Published:
Report ID: 42148

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN